These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26934062)

  • 41. Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.
    Rosenheck RA; Leslie DL; Sint KJ; Lin H; Li Y; McEvoy JP; Byerly MJ; Hamer RM; Swartz MS; Stroup TS
    Psychiatr Serv; 2016 Oct; 67(10):1124-1130. PubMed ID: 27247177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paliperidone extended-release in the short- and long-term treatment of schizophrenia.
    Valsecchi P; Garozzo A; Nibbio G; Barlati S; Deste G; Turrina C; Sacchetti E; Vita A
    Riv Psichiatr; 2019; 54(2):43-58. PubMed ID: 30985829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does Half-Life Matter After Antipsychotic Discontinuation? A Relapse Comparison in Schizophrenia With 3 Different Formulations of Paliperidone.
    Weiden PJ; Kim E; Bermak J; Turkoz I; Gopal S; Berwaerts J
    J Clin Psychiatry; 2017 Jul; 78(7):e813-e820. PubMed ID: 28640988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of carbamazepine on the pharmacokinetics of paliperidone extended-release tablets at steady-state.
    Kerbusch-Herben V; Cleton A; Berwaerts J; Vandebosch A; Remmerie B
    Clin Pharmacol Drug Dev; 2014 Sep; 3(5):371-7. PubMed ID: 27129010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The three-monthly paliperidone palmitate depot in the treatment of schizophrenia].
    Spoelstra SK; Bais L; Knegtering H
    Tijdschr Psychiatr; 2018; 60(12):827-833. PubMed ID: 30536295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Developing an individualized treatment plan for patients with schizoaffective disorder: from pharmacotherapy to psychoeducation.
    Vieta E
    J Clin Psychiatry; 2010; 71 Suppl 2():14-9. PubMed ID: 21190648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management.
    Muthu MS; Sahu AK; Sonali ; Abdulla A; Kaklotar D; Rajesh CV; Singh S; Pandey BL
    Drug Deliv; 2016; 23(1):230-7. PubMed ID: 24853962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hospitalizations and economic analysis in psychotic patients with paliperidone palmitate long-acting injection.
    Mesones-Peral JE; Gurillo-Muñoz P; Sánchez-Sicilia MP; Miller A; Griñant-Fernández A
    Rev Psiquiatr Salud Ment; 2017; 10(1):33-37. PubMed ID: 27053545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Population Pharmacokinetics of Paliperidone Palmitate (Once-Monthly Formulation) in Japanese, Korean, and Taiwanese Patients With Schizophrenia.
    Shimizu H; Neyens M; De Meulder M; Gopal S; Tsukamoto Y; Samtani MN; Remmerie B
    Clin Pharmacol Drug Dev; 2020 Feb; 9(2):224-234. PubMed ID: 31876117
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of Paliperidone Palmitate Throughout a Schizoaffective Disorder Patient's Gestation Period.
    Zamora Rodríguez FJ; Benítez Vega C; Sánchez-Waisen Hernández MR; Guisado Macías JA; Vaz Leal FJ
    Pharmacopsychiatry; 2017 Jan; 50(1):38-40. PubMed ID: 27414740
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of Medicaid spending in schizoaffective patients treated with once monthly paliperidone palmitate or oral atypical antipsychotics.
    Xiao Y; Muser E; Fu DJ; Lafeuille MH; Pilon D; Emond B; Wu A; Duh MS; Lefebvre P
    Curr Med Res Opin; 2016; 32(4):759-69. PubMed ID: 26750639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response Surface Analysis and Nonlinear Optimization Algorithm for Maximization of Clinical Drug Performance: Application to Extended-Release and Long-Acting Injectable Paliperidone.
    Gomeni R; Bressolle-Gomeni F; Fava M
    J Clin Pharmacol; 2016 Oct; 56(10):1296-306. PubMed ID: 26899406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement.
    Muser E; Kozma CM; Benson CJ; Mao L; Starr HL; Alphs L; Fastenau J
    J Med Econ; 2015; 18(8):637-45. PubMed ID: 25851616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of Paliperidone Palmitate in Reducing Acute Psychiatric Service Use for Patients Suffering from Psychosis-A Retrospective Mirror-Image Study.
    Chan CT; Verma S; Subramaniam M; Abdin E; Tay J
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antidepressants and antipsychotics in the long-term treatment of bipolar disorder.
    Kusumakar V
    J Clin Psychiatry; 2002; 63 Suppl 10():23-8. PubMed ID: 12392350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidone.
    Schoretsanitis G; Spina E; Hiemke C; de Leon J
    Expert Rev Clin Pharmacol; 2018 Jun; 11(6):625-639. PubMed ID: 29776316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia.
    Schreiner A; Aadamsoo K; Altamura AC; Franco M; Gorwood P; Neznanov NG; Schronen J; Ucok A; Zink M; Janik A; Cherubin P; Lahaye M; Hargarter L
    Schizophr Res; 2015 Dec; 169(1-3):393-399. PubMed ID: 26431793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of paliperidone extended-release in treatment of schizoaffective disorder.
    Canuso CM; Turkoz I; Fu DJ; Bossie CA
    Neuropsychiatr Dis Treat; 2010 Oct; 6():667-79. PubMed ID: 20957127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.